[Experience with clinical use of human leukocyte interferon in cancer of the cervix uteri].
Interferon was injected intracervically as the first stage of combination treatment in 110 cases of histologically-verified Ca in situ and invasive cervical carcinoma. Colpomicroscopic, cytologic and histologic examination was carried before and after treatment. Posttreatment histologic examination failed to detect any tumor cells in 31 patients (28.1%). Pronounced antitumor action of interferon was established.
D002277:Carcinoma / Q000473:pathology / Q000628:therapy*; D002278:Carcinoma in Situ / Q000473:pathology / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000628:therapy*; D002584:Cervix Uteri / Q000473:pathology; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000008:administration & dosage / Q000627:therapeutic use*; D002583:Uterine Cervical Neoplasms / Q000473:pathology / Q000628:therapy*
D007370:Interferon Type I
Opyt klinicheskogo primeneniia chelovecheskogo leĭkotsitarnogo interferona pri rake sheĭki matki.